Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 2014 Five-Year Relative Survival Rates Top Five Causes of Cancer
Document related concepts
Transcript
www.pancan.org | 877-272-6226 2014 Five-Year Relative Survival Rates Top Five Causes of Cancer Death 100% Five-year relative survival rate 100% 90% 80% Pancreatic Cancer Is Still the Deadliest Cancer, and the Threat Is Growing The five-year relative survival rate for pancreatic cancer is just 6%, and there are still no early detection tools and only minimally effective treatments. Even more alarming, it is projected to surpass breast and colorectal cancer to become the second leading cause of cancer-related death in the United States by 2020. 65% 60% 40% 20% 18% 6% 0% Lung Colon Breast Pancreas Prostate Cancer Sites “Major cancer” is defined as one tracked by both the American Cancer Society and the National Cancer Institute. ©2014 Pancreatic Cancer Action Network. All Rights Reserved. Source: American Cancer Society. Cancer Facts and Figures, 2014. Atlanta: American Cancer Society, 2014. Pancreatic Cancer Action Network National Headquarters | 1500 Rosecrans Ave. Suite 200 | Manhattan Beach, CA 90266 | Tel: 877-272-6226 Government Affairs & Advocacy Office | 1050 Connecticut Ave. NW, 10th Floor | Washington, DC 20036 | Ph: 202-742-6699 | Fx: 202-742-6518 www.pancan.org www.pancan.org | 877-272-6226 National Cancer Institute (NCI) Annual Funding Top Five Causes of Cancer Death 2003‐20121 2003 2004 2005 2006 2007 2008 2009 ARRA 2010 2011 2012 $700 $500 2003 2004 2005 2006 2007 2008 2009ARRA 2010 2011 2012 $200 2003 2004 2005 2006 2007 2008 2009 ARRA 2010 2011 2012 $300 2003 2004 2005 2006 2007 2008 2009 ARRA 2010 2011 2012 $400 2003 2004 2005 2006 2007 2008 2009 ARRA 2010 2011 2012 Funding (in millions) $600 $100 $0 Lung Colon Breast Pancreas Prostate Cancer sites Sources: NCI Annual Fact Books and NCI Funded Research Portfolio http://fundedresearch.cancer.gov. Accessed May 2013. Number of Drug Approvals, Including New Indications Top Five Causes of Cancer Death 2004‐2013 Number of approvals, including new indications 16 14 2013 2013 12 2012 10 2013 8 2007 2010 2006 4 2 2011 2013 2007 2005 2010 2009 2008 2004 2006 0 Colon 2012 2006 2011 2005 2010 2004 2004 Lung Federal investment in cancer research has led to new treatments and improved survival rates for other diseases. We now need the same type of results in pancreatic cancer. The NCI has issued a “scientific framework” (strategic plan) for pancreatic cancer as a result of the Recalcitrant Cancer Research Act of 2012, but it will be very difficult to leverage the opportunities that could result from the new report unless NCI funding levels improve. 2012 2012 6 Increased Investment Can Change the Prediction Breast 2013 2005 Pancreatic adenocarcinoma 2008 2004 Prostate Cancer sites Sources: Food and Drug Administration Cancer www.fda.govsites and National Cancer Institute www.cancer.gov. Accessed June 2013 and January 2014. 1 Under the American Recovery and Reinvestment Act (ARRA) of 2009, NCI received supplemental funding for 2009 and 2010 only. The 2010 data have not been published. ©2014 Pancreatic Cancer Action Network. All Rights Reserved Pancreatic Cancer Action Network | 1500 Rosecrans Ave. Suite 200 | Manhattan Beach, CA 90266 | Tel: 877-272-6226 | www.pancan.org Government Affairs & Advocacy Office | 1050 Connecticut Ave. NW, 10th Floor | Washington, DC 20036 | Ph: 202-742-6699 | Fx: 202-742-6518 . REV 2-14
